ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 707,93
0,34%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Graphite Bio Inc (GRPH)

  7. Graphite Bio Inc (GRPH) Actualités

GRPH

Graphite Bio (GRPH)

Graphite Bio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GRPH
DateHeureSourceTitreSymboleSociété
08/03/202423h17Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:GRPHGraphite Bio Inc
08/03/202423h13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRPHGraphite Bio Inc
08/03/202423h00Business WireGraphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz TherapeuticsNASDAQ:GRPHGraphite Bio Inc
27/02/202422h11Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GRPHGraphite Bio Inc
13/02/202422h44Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GRPHGraphite Bio Inc
09/02/202423h23Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:GRPHGraphite Bio Inc
05/02/202422h31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GRPHGraphite Bio Inc
06/12/202322h57Edgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:GRPHGraphite Bio Inc
15/11/202313h00Business WireLENZ Therapeutics and Graphite Bio Announce Merger AgreementNASDAQ:GRPHGraphite Bio Inc
13/09/202322h06Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:GRPHGraphite Bio Inc
14/08/202323h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GRPHGraphite Bio Inc
21/07/202323h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GRPHGraphite Bio Inc
23/06/202313h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRPHGraphite Bio Inc
23/06/202313h00Business WireGraphite Bio Announces Departure of Chief Financial OfficerNASDAQ:GRPHGraphite Bio Inc
06/06/202322h16Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:GRPHGraphite Bio Inc
06/06/202322h06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GRPHGraphite Bio Inc
11/05/202322h13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GRPHGraphite Bio Inc
20/03/202321h18Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GRPHGraphite Bio Inc
20/03/202321h12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GRPHGraphite Bio Inc
20/03/202321h05Business WireGraphite Bio Reports Recent Business Progress and Fourth Quarter and Fiscal Year 2022 Financial ResultsNASDAQ:GRPHGraphite Bio Inc
22/02/202322h05Business WireGraphite Bio Announces Process to Explore Strategic Alternatives and Corporate RestructuringNASDAQ:GRPHGraphite Bio Inc
05/01/202322h05Business WireGraphite Bio Announces Voluntary Pause of Phase 1/2 CEDAR Study of nulabeglogene autogedtemcel (nula-cel) for Sickle Cell DiseaseNASDAQ:GRPHGraphite Bio Inc
12/12/202214h42Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GRPHGraphite Bio Inc
11/12/202216h00Business WireGraphite Bio Presents Preclinical Data for Novel Sequencing Method Used to Determine Gene Editing Outcomes at 64th ASH Annual MeetingNASDAQ:GRPHGraphite Bio Inc
21/11/202214h00Business WireGraphite Bio Announces Participation in Evercore ISI 5th Annual HealthCONx ConferenceNASDAQ:GRPHGraphite Bio Inc
14/11/202205h05TipRanksBTIG Sticks to Their Buy Rating for Graphite Bio (GRPH)NASDAQ:GRPHGraphite Bio Inc
14/11/202204h55TipRanksSVB Securities Sticks to Its Buy Rating for Graphite Bio (GRPH)NASDAQ:GRPHGraphite Bio Inc
11/11/202202h49TipRanksGraphite Bio (GRPH) Receives a Hold from RBC CapitalNASDAQ:GRPHGraphite Bio Inc
09/11/202222h05Business WireGraphite Bio Reports Recent Business Progress and Third Quarter 2022 Financial ResultsNASDAQ:GRPHGraphite Bio Inc
03/11/202214h05Business WireGraphite Bio Announces Abstracts Accepted for Upcoming 64th ASH Annual Meeting and ExpositionNASDAQ:GRPHGraphite Bio Inc
 Showing the most relevant articles for your search:NASDAQ:GRPH

Dernières Valeurs Consultées

BIT
P222L2
NLBNPIT222L2 20351219 18...
BIT
P220M4
NLBNPIT220M4 20240621 34
NASDAQ
CLAQ
CleanTech Acquisition
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés